University of MichiganAnn Arbor, MI, United States
Disclosures:
3264 - Ultra-Short-Course Hormone Therapy for Intermediate Risk Prostate Cancer Treated with Definitive Radiotherapy: Retrospective Analysis of a National Healthcare System
Tuesday, October 1, 20242:30 PM – 3:45 PM ET